Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Abramson Cancer Center At Penn Medicine

Clinical trials sponsored by Abramson Cancer Center At Penn Medicine, explained in plain language.

Trials to join now! 48 Not yet recruiting 6 Not yet finished but already full! 43 Completed 28 Terminated 1

New drug combo tested for Tough-to-Treat blood cancers

Disease control Terminated

This early-phase study tested whether adding the drug rapamycin to a standard high-dose chemotherapy regimen (HiVAC) was safe and effective for adults with aggressive blood cancers that had returned or stopped responding to previous treatments. The goal was to see if this combina…

Phase: PHASE1, PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC